Skip to main content
Insulin-Degrading Enzyme Inhibition, a Novel Therapy for Type 2 Diabetes?
Published Web Location
http://www.sciencedirect.com/science/article/pii/S1550413114003246No data is associated with this publication.
Abstract
The insulin-degrading enzyme (IDE) has been identified as a type 2 diabetes and Alzheimer's disease susceptibility gene, though its physiological function remains unclear. Maianti et al. (2014) now propose that an IDE inhibitor may be a promising therapeutic strategy for type 2 diabetes.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.